Cargando...
Treatment strategy for colorectal cancer with resectable synchronous liver metastases: Is any evidence-based strategy possible?
Fifteen percent to twenty-five percent of patients affected by colorectal cancer presents with liver metastases at diagnosis. In resectable cases, surgery is the only potentially curative treatment and achieves survival rates up to 50% at 5 years. Management is complex, as colorectal resection, live...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Baishideng Publishing Group Co., Limited
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3443705/ https://ncbi.nlm.nih.gov/pubmed/22993665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v4.i8.237 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|